Cronos Group Inc. will hold a first quarter 2022 earnings conference call on May 10, 2022

0

Ayurcann Holdings Corp. (CSE: AYUR) (OTCQB: AYURF) (FSE: 3ZQ0) (“Ayurcann” or the “Company”), a leading Canadian cannabis extraction company specializing in the processing and co-manufacturing of cannabis and hemp from pharmaceutical grade to produce various Cannabis 2.0 and 3.0 derivative products for the medical and recreational market, is pleased to announce that it has received its Flower Sales License Amendment from Health Canada effective April 19, 2022 (the “Licence selling flowers”). The flower sales license will allow Ayurcann to sell dried cannabis flower products in Canada through authorized distributors and retailers.

“With our specialty in extraction and Cannabis 2.0 brands in Vapes and Oils available everywhere Canada , obtaining the flower sales license is another way for Ayurcann to gain market share and pursue higher-margin growth in the cannabis market. With our current suppliers and significant buying power, we can leverage our current relationships by offering an expanded portfolio of other products for the value-conscious consumer. Our offerings will include pre-rolls and dried flowers,” said Igal Sudman managing director of Ayurcann.

Cannabis flower is in high demand by provincial distributors and consumers. With national distribution and large-scale production capacity, the new flower preservation units (” SKUs “) will help Ayurcann grow and increase sales, while continuing to be profitable and gain market share.

Ayurcann is a leading post-harvest solutions provider focused on providing and creating custom process and pharmaceutical grade products for adult use and the medical cannabis industry in Canada . Ayurcann strives to become a partner of choice for leading Canadian and international cannabis brands by providing best in class proprietary services including extraction, formulation, product development and custom manufacturing.

Neither the Canadian Securities Exchange nor its regulation services provider has reviewed or accepts responsibility for the adequacy or accuracy of this release.

Forward-looking statements

This press release contains “forward-looking statements” within the meaning of applicable securities laws. Any statements contained herein that are not clearly historical in nature may constitute forward-looking statements. Generally, such forward-looking information or forward-looking statements can be identified by the use of forward-looking terminology such as “anticipates”, “expects” or “does not expect”, “is expected”, ” budget”, “expected”, “estimates”, “plans”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of these words and expressions or may contain statements that certain actions, events or results “could”, “could”, “would”, “could” or “will be taken”, “will continue”, “will occur” or “will be achieved”. forward-looking statements contained herein include, but are not limited to, statements regarding: the Company selling dried cannabis flower products pursuant to the Flower Sales License; Ayurcann uses the Flower Sales License as an alternative gain market share and pursue margin growth higher in the cannabis market; the Company leveraging its current relationships by offering an expanded portfolio of products, including pre-rolls and dried flowers; new flower references that contribute to Ayurcann’s growth and increased sales; Ayurcann increases its visibility and market share throughout the country; Ayurcann maintains a continuous trajectory of profitability and growth; and the Company’s ability to become the partner of choice for major Canadian cannabis brands.

The forward-looking information contained in this press release is based on certain assumptions and expected future events, namely: the Company will expand and be able to maintain its production capacity; the Company’s ability to continue as a going concern; the continued approval of the Company’s activities by the relevant governmental and/or regulatory authorities; the continued growth of the Company; the Company’s successful execution of its strategy to grow its market share in mining and mining derivatives while delivering exceptional products to consumers; the Company’s continued ability to meet the requirements necessary to remain listed on the Canadian Securities Exchange and other stock exchanges; the Company selling dried cannabis flower products pursuant to the Flower Sales License; Ayurcann is using the flower sales license as another way to gain market share and pursue higher margin growth in the cannabis market; the Company leveraging its current relationships by offering an expanded portfolio of products, including pre-rolls and dried flowers; new flower references that contribute to Ayurcann’s growth and increased sales; Ayurcann increases its visibility and market share throughout the country; Ayurcann maintains a continuous trajectory of profitability and growth; and the Company becoming the partner of choice for major Canadian cannabis brands.

These statements involve known and unknown risks, uncertainties and other factors, which may cause actual results, performance or achievements to differ materially from those expressed or implied by such statements, including, but not limit thereto: the Company’s inability to expand and/or maintain production capacity; the Company’s potential inability to continue its operations; risks associated with the cannabis industry generally; increased competition in the cannabis extraction market; the potential future unviability of the cannabis market; the risks associated with possible governmental and/or regulatory actions regarding the cannabis industry; the Company’s inability to obtain ongoing regulatory approvals ; the Company’s inability to successfully implement its strategy to expand mining and mining derivatives market share while offer exceptional products to consumers ; the Company’s failure to meet the requirements necessary to remain listed on the Canadian Securities Exchange and other stock exchanges; the Company’s inability to sell dried cannabis flower products pursuant to the Flower Sales License and/or revocation of the Flower Sales License; Ayurcann may not use the flower sales license as another means of gaining market share and pursuing higher margin growth in the cannabis market; the Company’s inability to leverage its current relationships by offering an expanded portfolio of products, including pre-rolls and dried flowers; new flower references not being able to contribute to the growth and increase in sales of Ayurcann; the Company’s inability to increase its exposure and market share; the Company being unable to maintain a continued path of profitability and growth; and the Company’s inability to become the partner of choice for major Canadian cannabis brands.

Readers are cautioned that the foregoing list is not exhaustive. Readers are further cautioned not to place undue reliance on forward-looking statements, as there can be no assurance that the plans, intentions or expectations upon which they are based will occur. Such information, although considered reasonable by management when prepared, may prove to be incorrect and actual results may differ materially from those anticipated.

The forward-looking statements contained in this press release are expressly qualified by this cautionary statement and reflect the Company’s expectations as of the date hereof and are subject to change thereafter. The Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, estimates or opinions, future events or results or otherwise, or to explain any material differences between subsequent actual events and such forward-looking information. , except as required by applicable law.

SOURCEAyurcann Holdings Corp.

Quote Show original content to download multimedia: http://www.newswire.ca/en/releases/archive/April2022/20/c6046.html


Source link

Share.

Comments are closed.